392 related articles for article (PubMed ID: 33173417)
21. Nanotechnology platforms and physiological challenges for cancer therapeutics.
Kim KY
Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
[TBL] [Abstract][Full Text] [Related]
22. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
23. Nanotechnology, A Tool for Diagnostics and Treatment of Cancer.
Nasir A; Khan A; Li J; Naeem M; Khalil AAK; Khan K; Qasim M
Curr Top Med Chem; 2021; 21(15):1360-1376. PubMed ID: 34218784
[TBL] [Abstract][Full Text] [Related]
24. Carbon Nanotube as a Tool for Fighting Cancer.
Comparetti EJ; Pedrosa VA; Kaneno R
Bioconjug Chem; 2018 Mar; 29(3):709-718. PubMed ID: 29072905
[TBL] [Abstract][Full Text] [Related]
25. Synergistic Interplay of Medicinal Chemistry and Formulation Strategies in Nanotechnology - From Drug Discovery to Nanocarrier Design and Development.
Sunoqrot S; Hamed R; Abdel-Halim H; Tarawneh O
Curr Top Med Chem; 2017; 17(13):1451-1468. PubMed ID: 28017147
[TBL] [Abstract][Full Text] [Related]
26. Targeted nanoparticle-based drug delivery and diagnosis.
Emerich DF; Thanos CG
J Drug Target; 2007 Apr; 15(3):163-83. PubMed ID: 17454354
[TBL] [Abstract][Full Text] [Related]
27. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
Moritz M; Geszke-Moritz M
Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
[TBL] [Abstract][Full Text] [Related]
28. Protease-activated nanomaterials for targeted cancer theranostics.
Chan YC; Hsiao M
Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
[TBL] [Abstract][Full Text] [Related]
29. Recent progress in nanotechnology for cancer therapy.
Tang MF; Lei L; Guo SR; Huang WL
Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and Therapeutic Nanomedicine.
Joo J
Adv Exp Med Biol; 2021; 1310():401-447. PubMed ID: 33834444
[TBL] [Abstract][Full Text] [Related]
31. Supramolecular nanoscale assemblies for cancer diagnosis and therapy.
Coelho SC; Pereira MC; Juzeniene A; Juzenas P; Coelho MAN
J Control Release; 2015 Sep; 213():152-167. PubMed ID: 26160308
[TBL] [Abstract][Full Text] [Related]
32. Biomedical nanomaterials for imaging-guided cancer therapy.
Huang Y; He S; Cao W; Cai K; Liang XJ
Nanoscale; 2012 Oct; 4(20):6135-49. PubMed ID: 22929990
[TBL] [Abstract][Full Text] [Related]
33. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
34. Advancement of nanoscience in development of conjugated drugs for enhanced disease prevention.
Taneja P; Sharma S; Sinha VB; Yadav AK
Life Sci; 2021 Mar; 268():118859. PubMed ID: 33358907
[TBL] [Abstract][Full Text] [Related]
35. Carbon-based drug delivery carriers for cancer therapy.
Lim DJ; Sim M; Oh L; Lim K; Park H
Arch Pharm Res; 2014 Jan; 37(1):43-52. PubMed ID: 24234911
[TBL] [Abstract][Full Text] [Related]
36. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
37. Recent Advances and Implication of Bioengineered Nanomaterials in Cancer Theranostics.
Rai A; Noor S; Ahmad SI; Alajmi MF; Hussain A; Abbas H; Hasan GM
Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33494239
[TBL] [Abstract][Full Text] [Related]
38. Chitosan nanopolymers: An overview of drug delivery against cancer.
Shanmuganathan R; Edison TNJI; LewisOscar F; Kumar P; Shanmugam S; Pugazhendhi A
Int J Biol Macromol; 2019 Jun; 130():727-736. PubMed ID: 30771392
[TBL] [Abstract][Full Text] [Related]
39. Stimuli-responsive polymeric nanoparticles for nanomedicine.
Crucho CI
ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
[TBL] [Abstract][Full Text] [Related]
40. Cell membrane-derived nanoparticles: emerging clinical opportunities for targeted drug delivery.
Yurkin ST; Wang Z
Nanomedicine (Lond); 2017 Aug; 12(16):2007-2019. PubMed ID: 28745122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
